贾纳斯激酶
化学
效力
Janus激酶3
药理学
激酶
医学
行动方式
生物化学
体外
抗原提呈细胞
细胞毒性T细胞
作者
Peter Jones,Richard Storer,Yogesh Sabnis,Florian Wakenhut,Gavin A. Whitlock,Katherine S. England,T. MUKAIYAMA,Christoph M. Dehnhardt,Jotham W. Coe,Steve Kortum,Jill Chrencik,David G. Brown,Rhys Jones,John R. Murphy,Thean Yeoh,Paul Morgan,Iain Kilty
标识
DOI:10.1021/acs.jmedchem.6b01634
摘要
By use of a structure-based computational method for identification of structurally novel Janus kinase (JAK) inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode. Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in potent pan-JAK inhibitor 2 (PF-06263276), which was advanced into clinical studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI